Role Summary The Senior Manager – Market Access is the Engine Room of Pfizer India's institutional reimbursement strategy. This role owns the evidence, economic, and access-design machinery that enables the Policy and GKAM functions to operate with credibility and force.
Operating across Pfizer India's priority portfolio — Lorlatinib, Elranatamab, PCV20, Nurtec, Hympavzi, and Genryzon — the incumbent architects the HEOR models, partnership structures, and PAP/managed-entry designs that justify and sustain reimbursement across ESIC, state government programs, central federal accounts (CGHS, AFMS, Railways, AGIs), and private channels.
The role demands deep strategic autonomy, cross-functional alignment, and the ability to translate complex clinical and economic evidence into institutional access wins
Role Responsibilities
- Health Economics, Evidence & Value Strategy
Lead development and deployment of the full suite of access evidence: cost-effectiveness models, budget impact analyses (BIM), cost-offset models (in-house vs. SST referral), state budget liability models for rare disease, and disease burden frameworks. Produce and socialize localized HEOR outputs — including CEA studies and publications — calibrated to specific payer audiences (ESIC, state health assurance agencies, NTAGI, army/railway medical boards). Ensure India's HEOR strategy is aligned with global HEOR priorities and adapted for local institutional decision-making logic
- Access Partnership Design
Design and oversee access partnerships with diagnostic providers, vaccination program implementers, and healthcare ecosystem players — specifically where partnerships strengthen institutional capacity and create demand pull for Pfizer's portfolio. This includes diagnostic capability enhancement partnerships (e.g., ALK/BCMA testing within ESIC hospitals for Lorlatinib and Elranatamab), and programmatic vaccination implementation partnerships covering hesitancy, inoculation logistics, data recording, and impact evidence for PCV20.
- PAP Architecture & Managed Entry Design
Architect innovative patient access programs and managed entry agreements tailored to institutional purchasing mechanisms. This includes: 1+1 cycle-based PAPs for Central Rate Contract submissions (Army/Railway/CGHS) that reduce effective government cost without impacting global invoice price; patient-capped PAPs for ESIC Local Purchase / Special Sanction routes that guarantee Medical Superintendents fixed maximum liability per patient per year; and Annual-Cap structures for rare disease state co-funding (Hympavzi/Genryzon) that give state finance departments predictable exposure. Design covers financial modelling, structure, and governance; scheme execution and supply-side coordination sits with GKAM and Finance.
- Account-Level Access Strategy
Develop and own the access strategy for the assigned account cluster — either States (NHM, Ayushman, state health assurance schemes) or Federal/AGI accounts (ESIC, CGHS, AFMS, Railways, AGIs) — working in tight coordination with the GKAM and Policy leads. Responsibilities include account prioritization, reimbursement pathway mapping, formulary and RC inclusion strategy, and the design of access models specific to each account's procurement logic. Execution activities — RC/PO management, file co-creation, procurement follow-through — are GKAM responsibilities and are not within this role's scope.
- Cross-Functional Access Integration
Serve as the primary Market Access interface for Medical, HEOR, Government Affairs, Commercial, and above-country teams. Ensure access evidence and program designs are developed in tight coordination with Policy (who shapes the environment) and GKAM (who converts accounts), without duplicating or stepping into their functional mandates. Actively contribute to above-country access forums as the India SME on reimbursement evidence and PAP design. Maintain clean hand-off protocols between Access, Policy, and GKAM to preserve the integrity of the unified triad structure defined in the reimbursement blueprint.
Qualifications
- Science graduate with MBA (or equivalent postgraduate management qualification) from a reputed institution; additional certification in Health Economics or Health Policy is advantageous.
- undefined
- 10+ years of experience in Market Access, Key Accounts, or Health Economics roles within the pharmaceutical, biotech, or healthcare consulting sector; with demonstrated progression in scope and accountability.
- undefined
- Hands-on proficiency in health-economic modelling: BIM, cost-effectiveness / cost-benefit analysis, cost-offset models, and state budget liability modelling for rare diseases. Ability to critically direct and review HEOR outputs independently and translate
